PK Consultancy provides clinical pharmacology, pharmacokinetic, and PK/PD modeling and simulation expertise. We will work in an integrated manner with your team.Company Mission:Scientific excellence and skilled technical capabilities, with a focus on technical expertise being current and attention to detail.Provide high quality and consistent contracting servicesProvide clinical pharmacology services to all clients in need in a timely mannerFurther advance drug developmentCapabilities:Clinical and non-clinical NCA – Pharmacokinetic analysis plan (PKAP), PK analysis, TLG generation, report writingCompartmental and population PK and PKPD – MAP, Analysis dataset generation, analysis, progress development meetings, and reportGraphical data analysis – can be used during clinical and non-clinical drug development in order to better understand data and drive program decision makingPrediction of first in human PK using allometric scalingStudy types:FIH dose predictionDose escalation (with rapid turnaround)Single Ascending Dose (SAD)Multiple Ascending Doses (MAD)Food Effect (FE)Bioavailability/Bioequivalence (BA/BE)Drug-Drug Interaction (DDI)Special Population (hepatic and renal impairment)Phase 3 studiesPost-marketing support